IPO registrations (S-1, F-1) · Registrants
VOLITIONRX LTD
- SEC CIK
- 93314 · filings on EDGAR ↗
- Former names
- STANDARD CAPITAL CORP (1999–2011)
- Registration
- Form S-1, first filed 2012-08-03, last 2025-04-04; 4 initial registrations, 6 amendments
- Outcome
- Final prospectus filed 2015-02-09; declared effective 2012-10-25; withdrawal requested 2025-04-16
- Industry (SIC)
- In Vitro & In Vivo Diagnostic Substances 2835
- Incorporated in
- DE
- Business address
- 1489 WEST WARM SPRINGS ROAD, SUITE 110, Henderson, NV 89014
- EIN
- 91-1949078
- Ticker
- VNRX (NYSE)
- EDGAR entity type
- operating
- Insiders and CEO pay
- VOLITIONRX LTD on the corporate pages
Offering terms
- Final price
- $3.75 per share (424B4 filed 2015-02-09)
- Shares sold
- 2,475,000
- Gross proceeds
- $9,281,250 before underwriting discounts and any over-allotment option
- Listing
- OTCQB under the symbol VNRX
- Lead underwriters
- The Benchmark Company (247,500 shares)
- Syndicate
- Lake Street Capital Markets (866,250); National Securities Corporation (1,361,250)
Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.
On this site
- Business registration: VOLITIONRX LIMITED Fuzzy (name and state)
- Form D issuer: VOLITIONRX LTD EXACT (CIK (EXACT))
- SEC filer: STANDARD CAPITAL CORP EXACT (CIK (EXACT))
Filings 28
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2012-08-03 | S-1 | S-1 (registration) | VOLITIONRX LTD | 0001078782-12-001917 ↗ |
| 2012-09-13 | S-1/A | S-1/A (amendment) | VOLITIONRX LTD | 0001078782-12-002407 ↗ |
| 2012-10-04 | S-1/A | S-1/A (amendment) | VOLITIONRX LTD | 0001078782-12-002572 ↗ |
| 2012-10-25 | EFFECT | EFFECT (declared effective) | VOLITIONRX LTD | 9999999995-12-003083 ↗ |
| 2014-04-11 | S-1 | S-1 (registration) | VOLITIONRX LTD | 0001078782-14-000627 ↗ |
| 2014-04-25 | EFFECT | EFFECT (declared effective) | VOLITIONRX LTD | 9999999995-14-001136 ↗ |
| 2014-11-28 | S-1 | S-1 (registration) | VOLITIONRX LTD | 0001078782-14-002155 ↗ |
| 2015-01-08 | S-1/A | S-1/A (amendment) | VOLITIONRX LTD | 0001078782-15-000016 ↗ |
| 2015-01-08 | S-1/A | S-1/A (amendment) | VOLITIONRX LTD | 0001078782-15-000020 ↗ |
| 2015-01-23 | S-1/A | S-1/A (amendment) | VOLITIONRX LTD | 0001078782-15-000105 ↗ |
| 2015-02-04 | S-1/A | S-1/A (amendment) | VOLITIONRX LTD | 0001078782-15-000164 ↗ |
| 2015-02-05 | EFFECT | EFFECT (declared effective) | VOLITIONRX LTD | 9999999995-15-000306 ↗ |
| 2015-02-09 | 424B4 | 424B4 (final prospectus) | VOLITIONRX LTD | 0001078782-15-000181 ↗ |
| 2015-06-26 | EFFECT | EFFECT (declared effective) | VOLITIONRX LTD | 9999999995-15-001750 ↗ |
| 2015-09-18 | EFFECT | EFFECT (declared effective) | VOLITIONRX LTD | 9999999995-15-002543 ↗ |
| 2018-09-28 | EFFECT | EFFECT (declared effective) | VOLITIONRX LTD | 9999999995-18-002505 ↗ |
| 2018-10-15 | EFFECT | EFFECT (declared effective) | VOLITIONRX LTD | 9999999995-18-002627 ↗ |
| 2020-02-14 | EFFECT | EFFECT (declared effective) | VOLITIONRX LTD | 9999999995-20-000376 ↗ |
| 2021-11-08 | EFFECT | EFFECT (declared effective) | VOLITIONRX LTD | 9999999995-21-004240 ↗ |
| 2024-06-25 | EFFECT | EFFECT (declared effective) | VOLITIONRX LTD | 9999999995-24-001953 ↗ |
| 2025-04-04 | S-1 | S-1 (registration) | VOLITIONRX LTD | 0001477932-25-002474 ↗ |
| 2025-04-15 | EFFECT | EFFECT (declared effective) | VOLITIONRX LTD | 9999999995-25-001124 ↗ |
| 2025-04-16 | RW | RW (withdrawal request) | VOLITIONRX LTD | 0001477932-25-002795 ↗ |
| 2025-04-18 | EFFECT | EFFECT (declared effective) | VOLITIONRX LTD | 9999999995-25-001148 ↗ |
| 2025-07-14 | EFFECT | EFFECT (declared effective) | VOLITIONRX LTD | 9999999995-25-002249 ↗ |
| 2026-02-19 | EFFECT | EFFECT (declared effective) | VOLITIONRX LTD | 9999999995-26-000634 ↗ |
| 2026-07-17 | EFFECT | EFFECT (declared effective) | VOLITIONRX LTD | 9999999995-26-002355 ↗ |
| 2026-09-09 | EFFECT | EFFECT (declared effective) | VOLITIONRX LTD | 9999999995-26-002936 ↗ |
Prospectus pages read 2
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 2015-02-04 | S-1/A | registration statement | $1.75 | - | - | 0 | primary document; price sentence | document ↗ | ||
| 2015-02-09 | 424B4 | final prospectus | $3.75 | 2,475,000 | $9,281,250 | OTCQB VNRX | 3 | primary document; price sentence, shares headline, proceeds table, underwriting table 3, cover names 2 | document ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| Magallano Alexander B. | Director,Officer | Chief Executive Officer | 1 | 2011 | |
| Perez Rudy Belloy | Officer | Treasurer & Secretary | 1 | 2011 | |
| Colman Alan | Director | 31 | 2013–2026 | ||
| Faulkes Martin Charles | Director; Director,Officer | Executive Director | 40 | 2013–2024 | |
| Innes Guy Archibald | Director | 59 | 2013–2026 | ||
| Lewin Malcolm Thomas | Officer | PFO, ACCOUNTING OFFICER, TREAS; PFO, PAO, TREASURER | 2 | 2013–2014 | |
| Reynolds Cameron John | Director,Officer; Director,Officer,TenPercentOwner | CEO and President; President and CEO; PRESIDENT AND CEO; President & CEO | 52 | 2013–2026 | |
| Rootsaert Rodney Gerard | Director,Officer; Officer; Officer,TenPercentOwner | Secretary; SECRETARY | 49 | 2013–2026 | |
| Concord International Inc. | TenPercentOwner | 1 | 2014 | ||
| Skaff Habib | Director | 12 | 2014–2019 | ||
| O'Connell Michael James | Officer | Chief Financial Officer | 1 | 2014 | |
| KRATOCHVIL DAVID MATTHEW | Officer | Chief Financial Officer | 4 | 2015–2016 | |
| Micallef Jacob Vincent | Officer | Chief Scientific Officer | 50 | 2015–2026 | |
| TERRELL JASON BRADLEY MD | Officer | Chief Medical Officer | 25 | 2016–2022 | |
| Futcher Edward | Director | 15 | 2016–2024 | ||
| Vanston David Cecil | Officer | Chief Financial Officer; CHIEF FINANCIAL OFFICER | 8 | 2017–2020 | |
| Gaetan Michel | Officer; Other | Chief Operating Officer | 22 | 2017–2026 | |
| Cotterford Co Ltd | TenPercentOwner | 3 | 2019 | ||
| Eight Corp Ltd | TenPercentOwner | 5 | 2019–2024 | ||
| Barnes Phillip | Director | 14 | 2019–2026 | ||
| Kway Jasmine | Officer; Other | CEO - Singapore Volition; CEO -Singapore Volition; CEO, Singapore Volition; CEO-Singapore Volition | 21 | 2020–2026 | |
| Butera Salvatore Thomas | Director; Officer | CEO - Volition Veterinary; CEO Volition Veterinary; CEO, Volition Veterinary; CEO-Volition Veterinary | 42 | 2020–2026 | |
| Forterre Gael | Officer | Chief Commercial Officer; Chief Commerical Officer | 31 | 2021–2026 | |
| Hughes Terig | Officer | Chief Financial Officer | 20 | 2021–2026 | |
| Brudnick Richard | Director | 6 | 2021–2023 | ||
| Nguyen Kim | Director | 18 | 2021–2026 | ||
| Plummer Nicholas | Officer | GC - Volition Diagnostics; GC Volition Diagnostics; GC, Volition Diagnostics | 26 | 2021–2026 | |
| Henshall Mickie | Director | 6 | 2022–2026 | ||
| Batchelor Ann-Louise | Officer | Group Chief Marketing Officer | 22 | 2022–2026 | |
| Hever Investments Ltd | TenPercentOwner | 2 | 2023–2024 | ||
| Retter Andrew | Officer | Chief Medical Officer | 12 | 2024–2025 | |
| Rubin Ethel | Director | 8 | 2024–2026 | ||
| STILL TIMOTHY I | Director | 5 | 2024–2026 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Private offerings before or after (Form D)
| First filed | Issuer | Industry | Offering | Sold | Investors | Filings |
|---|---|---|---|---|---|---|
| 2025-05-30 | VOLITIONRX LTD | Biotechnology | $22,650,000 | $22,650,000 | 1 | 2 |
| 2024-03-26 | VOLITIONRX LTD | Biotechnology | $100,000 | $100,000 | 1 | 1 |
| 2018-08-27 | VOLITIONRX LTD | Biotechnology | $24,000,000 | $24,000,000 | 1 | 1 |
| 2014-11-21 | VOLITIONRX LTD | Biotechnology | $721,849 | $721,849 | 21 | 1 |
| 2014-10-14 | VOLITIONRX LTD | Biotechnology | $750,000 | $750,000 | 23 | 1 |
| 2014-10-14 | VOLITIONRX LTD | Biotechnology | $229,393 | $229,393 | 10 | 1 |
| 2014-09-25 | VOLITIONRX LTD | Biotechnology | $1,189,749 | $1,189,749 | 7 | 1 |
| 2014-03-11 | VOLITIONRX LTD | Biotechnology | $3,000,000 | $3,000,000 | 24 | 1 |
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.
Also on this site Fuzzy
| Record | Name as filed | Where | Dataset | Matched by |
|---|---|---|---|---|
| Business registration | VOLITIONRX LIMITED | NV | State business registries | name and state |
| Form D issuer | VOLITIONRX LTD | NV | Form D private offerings | CIK (EXACT) |
| SEC filer | VOLITIONRX LTD | SEC filers (EDGAR) | CIK (EXACT) |
Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.